1. P2–082: Florbetapir F18 PET identification of beta‐amyloid in the living brain: A consecutive clinical case series. (1st July 2013) Authors: Mitsis, Effie; Bender, Heidi; Kostakoglu, Lale; Machac, Josef; Martin, Jane; Woehr, Jennifer; Goldstein, Martin; Sano, Mary; Gandy, Sam Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 9 Page Start: P373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P2–083: Florbetapir scanning excludes Alzheimer's disease in a retired NFL player with delayed cognitive impairment. (1st July 2013) Authors: Mitsis, Effie; Riggio, Silvana; D'Antonio, Emily; Goldstein, Martin; DeKosky, Steven; Naidich, Thomas; Delman, Bradley; Machac, Josef; Elder, Gregory; Sano, Mary; Gandy, Sam; Gordon, Wayne Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 9 Page Start: P373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P4–409: Neat, but not beta‐amyloid–affinity‐depleted, Baxter Immune Globulin® modulates behavior in transgenic mouse expressing Dutch beta‐amyloid oligomers. (1st July 2013) Authors: Knight, Elysse; Szabo, Paul; Ehrlich, Michelle; Relkin, Norman; Gandy, Sam Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 22 Page Start: P885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗